SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-21-000904
Filing Date
2021-07-12
Accepted
2021-07-12 14:44:31
Documents
2
Group Members
COMMODORE CAPITAL MASTER LP

Document Format Files

Seq Description Document Type Size
1 SC 13G cymabay_13gjun302021.htm SC 13G 49324
2 JOINT FILING AGREEMENT cymabay_exhibit1jun302021.htm EX-1 3971
  Complete submission text file 0000905718-21-000904.txt   55026
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 211085339
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G